Sinusitis Studies For Nonantimicrobial Drugs Need Objective Endpoints – FDA
Clinical trials assessing nonantimicrobial drugs for treatment of acute, subacute or chronic sinusitis should include at least one objective endpoint to establish efficacy, an FDA 1draft guidance recommends
You may also be interested in...
Clinical trials for acute bacterial sinusitis therapies should be designed to show superiority of the investigative antimicrobial to placebo, members of FDA's Anti-Infective Drugs Advisory Committee said Oct. 29
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.